Hillenbrand Inc. has announced the sale of a 51% stake in its Milacron injection molding and extrusion business to an ...

German drugmaker Stada Arzneimittel AG could break open the market for European initial public offerings again as it gears up ...

Bain Capital, a leading private investment firm, today announced a majority investment in the Milacron Injection Molding and Extrusion business (or the "Company"), a globally renowned provider of ...

Leonteq AG (SIX: LEON) today announced the appointment of Christian Spieler as Leonteq’s CEO effective 1 March 2025.

Brookfield Capital Partners has joined the fight for takeover target Insignia Financial, matching offers from rivals Bain ...

Insignia Financial is now entertaining a trio of suitors after Brookfield Capital Partners joined the fight for the wealth ...

When PE firms push each other to the limit, the buyer often lives to regret it. Insignia Financial is a fascinating test.

Street Talk understands Brookfield has tapped Trans-Tasman investment bank Jarden and law firm Gilbert + Tobin for its run at the wealth management group.

Swiss derivatives specialist Leonteq issued a profit warning after the Swiss financial market regulator Finma confiscated more than 9 million francs in profits. As a result, the annual figures are ...

Japanese trading house Sumitomo Corp on Tuesday raised its net profit forecast for the fiscal year through March to 560 ...

Backed by top financial firms and billionaire philanthropists, including Bain Capital, Bank of America, Barry Sternlicht, ...

CEO Hess discussed the company's divestiture of TRANZACT for $632 million, expected to enhance growth, operating margins, and free cash flow starting in 2025. The reentry into the reinsurance market ...